The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: A case study

Journal of Psychopharmacology

Volumn 18, Issue 3, 2004, Pages 429-431

  Conley, Robert R ^a   Kelly, Deanna L ^a,b   Beason Held, Lori L ^a   Holcomb, Henry H ^a   Richardson, Charles M ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Brain; Human; Medication; Positron emmission tomography; Spatial

Indexed keywords

CLOZAPINE; OLANZAPINE;

ADULT; ARTICLE; BLOOD FLOWMETRY; BRAIN BLOOD FLOW; BRAIN FUNCTION; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROENCEPHALOGRAM; HUMAN; IMAGING SYSTEM; MALE; MENTAL TASK; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN; BRAIN MAPPING; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG RESISTANCE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; SCHIZOPHRENIA;

EID: 6044263758     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110401800315     Document Type: Article

References (7)

1. Beasley C J, Sanger T, Satterlee W, Tollefson G, Tran P, Hamilton S (1996) Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology (Berl) 124: 159-167
2. Conley R, Kelly D (2001) Management of treatment resistance in schizophrenia. Biol Psychiatry 50: 898-911
3. Conley R, Kelly D, Richardson C, Tamminga C, Carpenter W (2003) The efficacy of high dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study. J Clin Psychopharmacol 23: 668-671
4. Conley R R, Tamminga C A, Kelly D L, Richardson C (1999) Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry 46: 73-77
5. Friston K J, Worsley K J, Frackowiak R S J, Mazziotta J C, Evans A C (1994) Assessing the significance of focal activations using their spatial extent. Hum Brain Map 1: 210-220
6. Lahti A C, Holcomb H H, Weiler M A, Medoff D R, Tamminga C A (2003) Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry 53: 601-608
7. Muller J L, Roder C, Schuierer G, Klein H E (2002) Subcortical over-activation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study. Psychiatry Clin Neurosci 56: 77-84